ストックスクリーナーアプリを入手
5.27
0.77%
0.07
Opus Genetics Inc (IRD) 最新ニュース
Here is Why Opus Genetics (IRD) is One of the Best Performing NASDAQ Stocks - Yahoo Finance
Citizens reiterates Opus Genetics stock rating on FDA program acceptance - Investing.com UK
Citizens reiterates Opus Genetics stock rating on FDA program acceptance By Investing.com - Investing.com Australia
Opus Genetics’ LCA5 gene therapy accepted into FDA program - Investing.com
FDA rare-disease program takes in Opus therapy for childhood blindness - Stock Titan
Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program - GlobeNewswire
Citizens reiterates Opus Genetics stock rating on gene therapy data By Investing.com - Investing.com Australia
Citizens reiterates Opus Genetics stock rating on gene therapy data - Investing.com
Citizens Initiates Coverage on Opus Genetics with Outperform Rating - HarianBasis.co
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Opus Genetics (IRD), NeoGenomics (NEO) and Teladoc (TDOC) - The Globe and Mail
Citizens Initiates Coverage of Opus Genetics (IRD) - Insider Monkey
IRD Stock Price, Quote & Chart | OPUS GENETICS INC (NASDAQ:IRD) - ChartMill
B. Riley Securities Maintains Opus Genetics(IRD.US) With Buy Rating, Raises Target Price to $10 - Moomoo
B. Riley Adjusts Opus Genetics Price Target to $10 From $9, Maintains Buy Rating - marketscreener.com
Opus Genetics to Participate in Leading Medical Conferences in May 2026 - Sahm
IRD Initiated Coverage by Citizens -- Rating Set to Market Outpe - GuruFocus
Opus Genetics higher after $25M private placement - MSN
Citizens JMP Initiates Opus Genetics(IRD.US) With Buy Rating, Announces Target Price $12 - Moomoo
Opus Genetics (NASDAQ:IRD) Now Covered by Analysts at Citizens Jmp - MarketBeat
Citizens initiates Opus Genetics stock coverage with outperform rating - Investing.com UK
Citizens initiates Opus Genetics stock coverage with outperform rating By Investing.com - Investing.com Australia
Citizens Initiates Coverage of Opus Genetics (IRD) with Market Outperform Recommendation - MSN
Opus Genetics (NASDAQ:IRD) CFO Robert Gagnon Sells 7,842 Shares - MarketBeat
Opus Genetics (NASDAQ:IRD) CEO Sells $49,647.42 in Stock - MarketBeat
Opus Genetics president Benjamin Yerxa sells $39,121 in stock By Investing.com - Investing.com Australia
Opus Genetics president Benjamin Yerxa sells $39,121 in stock - Investing.com
Opus Genetics CEO George Magrath sells $49,647 in stock By Investing.com - Investing.com Australia
[Form 4] Opus Genetics, Inc. Insider Trading Activity - Stock Titan
Opus Genetics CSO Jayagopal Ashwath sells $39,155 in stock By Investing.com - Investing.com South Africa
Opus Genetics CEO George Magrath sells $49,647 in stock - Investing.com UK
Opus Genetics CSO Jayagopal Ashwath sells $39,155 in stock - Investing.com
Opus Genetics (IRD) COO sells shares to cover tax withholding - Stock Titan
Small Opus Genetics (IRD) insider sale made to cover RSU taxes - Stock Titan
Opus Genetics (IRD) CEO sells 9,511 shares to cover tax withholding - Stock Titan
Opus Genetics (IRD) officer auto-sells 7,542 shares for RSU taxes - Stock Titan
Opus Genetics (IRD) CFO has 7,842 shares sold to cover RSU taxes - Stock Titan
Opus Genetics (IRD) price target increased by 23.44% to 9.73 - MSN
Opus Genetics secures up to $155M financing from Oberland Capital - MSN
Opus Genetics, Inc. Files Form 8-K: Company Information, Address, and NASDAQ Listing Details - Minichart
Opus Genetics issues $35 million in senior secured notes under new agreement By Investing.com - Investing.com South Africa
Opus Genetics issues $35 million in senior secured notes under new agreement - Investing.com UK
0.78%
3.01%
大文字化:
|
ボリューム (24 時間):